Amino-terminal pro-brain natriuretic peptide as a prognostic marker in patients with rheumatoid arthritis

Clinical Rheumatology

Volumn 30, Issue 1, 2011, Pages 61-69

  Targońska Stȩpniak, Bozena ^a   Majdan, Maria ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

Amino terminal pro brain natriuretic peptide; Cardiovascular disease; Diseases activity; Rheumatoid arthritis

Indexed keywords

ADALIMUMAB; ALBUMIN; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; CHLOROQUINE; CYCLOSPORIN; CYSTATIN C; ETANERCEPT; HEMOGLOBIN; INFLIXIMAB; LEFLUNOMIDE; METHOTREXATE; PREDNISONE; RITUXIMAB; SALAZOSULFAPYRIDINE;

ADULT; AGED; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; DISEASE ACTIVITY; DISEASE MARKER; ECHOGRAPHY; ERYTHROCYTE COUNT; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; GENDER; GRIP STRENGTH; HAND GRIP; HUMAN; KIDNEY FUNCTION; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; RHEUMATOID ARTHRITIS; SKINFOLD;

ADOLESCENT; ADULT; ARTHRITIS, RHEUMATOID; BLOOD SEDIMENTATION; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CYSTATIN C; FEMALE; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PROGNOSIS; TUNICA INTIMA; TUNICA MEDIA; ULTRASONOGRAPHY;

EID: 79151476711     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-010-1622-0     Document Type: Article

References (44)

1. A Naranjo T Sokka MA Descalzo, et al. 2008 QUEST-RA Group: cardiovascular disease in patients with rheumatoid arthritis: results from the QUEST-RA study Arthritis Res Ther 10 R30 10.1186/ar2383 18325087
2. R Koivuniemi L Paimela M Leirisalo-Repo 2009 Causes of death in patients with rheumatoid arthritis from 1971 to 1991 with special reference to autopsy Clin Rheumatol 28 1443 1447 10.1007/s10067-009-1278-9 19760078
3. SE Gabriel 2008 Cardiovascular morbidity and mortality in rheumatoid arthritis Am J Med 121 S9 S14 10.1016/j.amjmed.2008.06.011 18926169
4. H Maradit-Kremers CS Crowson PJ Nicola, et al. 2005 Increased unrecognized coronary heart disease and sudden death in rheumatoid arthritis Arthritis Rheum 52 402 411 10.1002/art.20853 15693010
5. J Holly G Kitas T Toms N Goodson 2009 Cardiovascular co-morbidity in early rheumatoid arthritis Best Pract Res Clin Rheumatol 23 71 82 10.1016/j.berh.2008.11.007
6. PH Dessein GR Norton AJ Woodiwiss, et al. 2007 Influence of nonclassical cardiovascular risk factors on the accuracy of predicting subclinical atherosclerosis in rheumatoid arthritis J Rheumatol 34 943 951 17444592
7. MA Gonzalez-Gay C Gonzalez-Juanatey A Piñeiro, et al. 2005 High-grade C-reactive protein elevation correlates with accelerated atherogenesis in patients with rheumatoid arthritis J Rheumatol 32 1219 1223 1:CAS:528:DC%2BD2MXnsl2nsro%3D 15996055
8. T Nishikimi N Maeda H Matsuoka 2006 The role of natriuretic peptides in cardioprotection Cardiovasc Res 69 318 328 1:CAS:528:DC%2BD28Xls1Wrug%3D%3D 10.1016/j.cardiores.2005.10.001 16289003
9. GM Felker JW Petersen DB Mark 2006 Natriuretic peptides in the diagnosis and management of heart failure CMAJ 175 611 617 16966666
10. TJ Wang MG Larson D Levy, et al. 2004 Plasma natriuretic peptide levels and the risk of cardiovascular events and death N Eng J Med 350 655 663 1:CAS:528:DC%2BD2cXhtFCrtrg%3D 10.1056/NEJMoa031994
11. MH Olsen TW Hansen MK Christensen, et al. 2007 N-terminal pro-brain natruretic peptide, but not high sensitivity C-reactive protein, improves cardiovascular risk prediction in the general population Eur Heart J 28 1374 1381 1:CAS:528:DC%2BD2sXot1agt7s%3D 10.1093/eurheartj/ehl448 17242007
12. K Tsuchida K Tanabe 2008 Plasma brain natriuretic peptide concentrations and the risk of cardiovascular events and death in general practice J Cardiol 52 212 223 10.1016/j.jjcc.2008.07.007 19027599
13. GC Linssen SJ Bakker AA Voors, et al. 2010 N-terminal pro-B-type natriuretic peptide is an independent predictor of cardiovascular morbidity and mortality in the general population Eur Heart J 31 120 127 1:CAS:528: DC%2BC3cXhtFOlsA%3D%3D 10.1093/eurheartj/ehp420 19854731
14. EC Korngold JL Januzzi Jr ML Gantzer, et al. 2009 Amino-terminal pro-B-type natriuretic peptide and high-sensitivity C-reactive protein as predictors of sudden cardiac death among women Circulation 119 2868 2876 1:CAS:528:DC%2BD1MXms1alsLg%3D 10.1161/CIRCULATIONAHA.108.832576 19470888
15. E Barbato S Rubattu J Bartunek, et al. 2009 Human coronary atherosclerosis modulates cardiac natriuretic peptide release Atherosclerosis 206 258 264 1:CAS:528:DC%2BD1MXhtVKlsLrN 10.1016/j.atherosclerosis.2009.01.033 19237156
16. J Solus CP Chung A Oeser, et al. 2008 Amino-terminal fragment of the prohormone brain-type natriuretic peptide in rheumatoid arthritis Arthritis Rheum 58 2662 2669 10.1002/art.23796 18759301
17. SA Provan K Angel S Edegard, et al. 2008 The association between disease activity and NT-proBNP in 238 patients with rheumatoid arthritis: a 10-year longitudinal study Arthritis Res Ther 10 R70 10.1186/ar2442 18573197
18. SMJ Harney J Timperley C Daly, et al. 2007 Brain natriuretic peptide is a potentially useful screening tool for the detection of cardiovascular disease in patients with rheumatoid arthritis Ann Rheum Dis 65 136 10.1136/ard.2005. 040634
19. O Karadag M Calguneri B Yavuz, et al. 2007 B-type natriuretic peptide (BNP) levels in female systemic lupus erythematosus patients: what is the clinical significance? Clin Rheumatol 26 1701 1704 10.1007/s10067-007-0575-4 17318274
20. S Provan K Angel AG Semb, et al. 2010 NT-proBNP predicts mortality in patients with rheumatoid arthritis: results from 10-year follow-up of the EURIDISS study Ann Rheum Dis 10.1136/ard.2009.127704
21. FC Arnett SM Edworthy DA Bloch, et al. 1988 The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis Arthritis Rheum 31 315 324 1:STN:280:DyaL1c7pt1Ohsg%3D%3D 10.1002/art. 1780310302 3358796
22. ML Prevoo MA vant't Hof HH Kuper, et al. 1995 Modified disease activity scores that include twenty-eight-joint counts: development and validation in a prospective longitudinal study of patients with rheumatoid arthritis Arthritis Rheum 38 44 48 1:STN:280:DyaK2M7hvVeqtA%3D%3D 10.1002/art.1780380107 7818570
23. T Pincus T Sokka H Kautiainen 2005 Further development of a physical function scale on a MDHAQ [corrected] for standard care of patients with rheumatic diseases J Rheumatol 32 1432 1439 16078316
24. DW Cockroft MH Gault 1976 Preddiction of creatinine clearance from serum creatinine Nephron 16 31 41 10.1159/000180580
25. AS Levey JP Bosch JB Lewis, et al. 1999 A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of diet in renal disease study group Ann Intern Med 130 461 470 1:CAS:528:DyaK1MXitFChs7k%3D 10075613
26. MG Shlipak R Katz MJ Sarnak, et al. 2006 Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease Ann Intern Med 145 237 247 1:CAS:528:DC%2BD28XpsFejtb0%3D 16908914
27. K Brune HA Katus J Moecks, et al. 2008 N-terminal pro-B-type natriuretic peptide concentrations predict the risk of cardiovascular adverse events form anti-inflammatory drugs: a pilot study Clin Chem 54 1149 1157 1:CAS:528:DC%2BD1cXot1amsLo%3D 10.1373/clinchem.2007.097428 18451314
28. P Poredos 2004 Intima-media thickness: indicator of cardiovascular risk and measure of the extent of atherosclerosis Vasc Med 9 46 54 10.1191/1358863x04vm514ra 15230488
29. C Gonzalez-Juanatey J Llorca J Martin MA Gonzalez-Gay 2009 Carotid intima-media thickness predicts the development of cardiovascular events in patients with rheumatoid arthritis Semin Arthritis Rheum 38 366 371 10.1016/j.semarthrit.2008.01.012 18336869
30. MG Veller CM Fisher AN Nicolaides, et al. 1993 Measurement of the ultrasonic intima-media complex thickness in normal subjects J Vasc Surg 17 719 725 1:STN:280:DyaK3s3hvVShsw%3D%3D 10.1067/mva.1993.41133 8464091
31. O Steinbrocker H Treger H Cornelius 1949 Therapeutic criteria in rheumatoid arthritis JAMA 140 659 662 1:STN:280:DyaH1M%2FltFyltw%3D%3D
32. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults 2001 Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on detection and treatment of high blood cholesterol in adults (Adult treatment Pannel III) JAMA 285 2468 2497 10.1001/jama.285.19.2486
33. MJL Peters P Welsh IB McInnea, et al. 2010 TNFα blockade therapy reduces circulating NT-proBNP levels in RA patients with active disease: results from prospective cohort study Ann Rheum Dis 69 1281 1285 1:CAS:528: DC%2BC3cXhtVSltbfP 10.1136/ard.2009.119412 19934107
34. G Belcaro AN Nicolaides G Ramaswami, et al. 2001 Carotid and femoral ultrasound morphology screening and cardiovascular events in low risk subjects: a 10-year follow-up study (the CAFES-CAVE study) Atherosclerosis 156 379 387 1:CAS:528:DC%2BD3MXktVKqtb8%3D 10.1016/S0021-9150(00)00665-1 11395035
35. MA Gonzalez-Gay C Gonzalez-Juanatey TR Vazquez-Rodriguez, et al. 2008 Endothelial dysfunction, carotid intima-media thickness, and accelerated atherosclerosis in rheumatoid arthritis Semin Arthritis Rheum 38 67 70 10.1016/j.semarthrit.2008.02.001 18395772
36. MA Crilly HJ Clark V Kumar, et al. 2010 Relationship between arterial stiffness and Stanford Health Assessment Questionnaire disability in rheumatoid arthritis patients without overt arterial disease J Rheumatol 37 946 952 10.3899/jrheum.091052 20231203
37. S Linzbach A Samigullin S Yilmaz, et al. 2009 Role of N-terminal pro-brain natriuretic peptide and cystatin C to estimate renal function in patients with and without heart failure Am J Cardiol 103 1128 1133 1:CAS:528:DC%2BD1MXktl2jsbc%3D 10.1016/j.amjcard.2009.01.009 19361601
38. CR DeFilippi JC Fink CM Nass, et al. 2005 N-terminal pro-B-type natriuretic peptide for predicting coronary disease and left ventricular hypertrophy in asymptomatic CKD not requiring dialysis Am J Kidney Dis 46 35 44 1:CAS:528:DC%2BD2MXmvVaqur8%3D 10.1053/j.ajkd.2005.04.007 15983955
39. A Luchner C Hengstenberg H Löwel, et al. 2005 Effect of compensated renal dysfunction on approved heart failure markers: direct comparison of brain natriuretic peptide (BNP) and N-Terminal Pro-BNP Hypertension 46 118 123 1:CAS:528:DC%2BD2MXlt1WltLs%3D 10.1161/01.HYP.0000170140.36633.8f 15939804
40. M Matsumoto T Tsujino Y Naito, et al. 2008 Anemia as a factor that elevates plasma brain natriuretic peptide concentration in apparently healthy subjects Int Heart J 49 577 586 1:CAS:528:DC%2BD1cXhsVSjurvF 10.1536/ihj.49.577 18971569
41. AS Desai K Bibbins-Domingo MG Shlipak, et al. 2007 Association between anaemia and N-terminal pro-B-type natriuretic peptide (NT-proBNP): findings from the heart and soul study Eur J Heart Fail 9 886 891 1:CAS:528: DC%2BD2sXpvF2rsro%3D 10.1016/j.ejheart.2007.06.005 17627881
42. C Gómez-Vaquero JM Nolla J Fiter, et al. 2001 Nutritional status in patients with rheumatoid arthritis Joint Bone Spine 68 403 409 10.1016/S1297-319X(01)00296-2 11707006
43. O Heimbürger AR Qureshi WS Blaner, et al. 2000 Hand-grip muscle strength, lean body mass, and plasma proteins as markers of nutritional status in patients with chronic renal failure close to start of dialysis therapy Am J Kidney Dis 36 1213 1225 10.1053/ajkd.2000.19837 11096047
44. Q Guo P Bárány AR Qureshi, et al. 2009 N-terminal pro-brain natriuretic peptide independently predicts protein energy wasting and is associated with all-cause mortality in prevalent HD patients Am J Nephrol 29 516 523 1:CAS:528:DC%2BD1MXmslCju7g%3D 10.1159/000185628 19077418